StockData
SpyGlass Pharma, Inc. logo

SpyGlass Pharma, Inc. (SGP) SEC filings

SGPNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$32.88−0.44 (-1.32%)

Close on Nov 13, 2026Market cap $1.10BP/E –Yield –

SEC filings

13 of SpyGlass Pharma's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Quarterly report10-QSep 30, 2026Nov 12, 2026SEC EDGAR
Current report8-KNov 11, 2026Nov 12, 2026SEC EDGAR
Current report8-KOct 19, 2026Oct 19, 2026SEC EDGAR
Current report8-KOct 1, 2026Oct 1, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Aug 6, 2026SEC EDGAR
Current report8-KAug 6, 2026Aug 6, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 14, 2026SEC EDGAR
Current report8-KMay 14, 2026May 14, 2026SEC EDGAR
Annual report10-KDec 31, 2025Mar 26, 2026SEC EDGAR
Current report8-KMar 26, 2026Mar 26, 2026SEC EDGAR
Current report8-KMar 9, 2026Mar 9, 2026SEC EDGAR
Current report8-KFeb 12, 2026Feb 13, 2026SEC EDGAR
Current report8-KFeb 5, 2026Feb 9, 2026SEC EDGAR

See a number that looks wrong?